Accessibility Menu
 
Drägerwerk Ag & KGaA logo

Drägerwerk Ag & KGaA

(ETR) DRW3

Current Price$89.90
Market Cap$1.75B
Since IPO (1992)+1,141%
5 Year+33%
1 Year+49%
1 Month+2%

Drägerwerk Ag & KGaA Financials at a Glance

Market Cap

$1.75B

Revenue (TTM)

$3.48B

Net Income (TTM)

$139.50M

EPS (TTM)

$7.44

P/E Ratio

12.53

Dividend

$2.03

Beta (Volatility)

0.02 (Low)

Price

$89.90

Volume

9,118

Open

$92.80

Previous Close

$93.30

Daily Range

$89.60 - $92.90

52-Week Range

$56.00 - $96.20

DRW3 News

No articles available.

DRW3: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drägerwerk Ag & KGaA

Industry

Healthcare Equipment and Supplies

Employees

16,687

CEO

Stefan Dräger

Headquarters

Lübeck, 23558, DE

DRW3 Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

7%

Net Income Margin

4%

Return on Equity

9%

Return on Capital

10%

Return on Assets

4%

Earnings Yield

7.98%

Dividend Yield

0.02%

Payout Ratio

26.86%

Stock Overview

Market Cap

$1.75B

Shares Outstanding

18.76M

Volume

9.12K

Short Interest

0.00%

Avg. Volume

19.77K

Financials (TTM)

Gross Profit

$1.52B

Operating Income

$238.28M

EBITDA

$384.83M

Operating Cash Flow

$238.33M

Capital Expenditure

$71.82M

Free Cash Flow

$166.50M

Cash & ST Invst.

$284.06M

Total Debt

$405.11M

Drägerwerk Ag & KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.14B

+5.8%

Gross Profit

$517.67M

+4.8%

Gross Margin

45.47%

N/A

Market Cap

$1.75B

N/A

Market Cap/Employee

$113.33K

N/A

Employees

15,444

N/A

Net Income

$94.65M

+24.5%

EBITDA

$189.31M

+10.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$121.05M

+17.9%

Accounts Receivable

$947.28M

+10.4%

Inventory

$636.07M

-2.8%

Long Term Debt

$293.37M

+2.2%

Short Term Debt

$111.73M

+2.8%

Return on Assets

4.26%

N/A

Return on Invested Capital

9.71%

N/A

Free Cash Flow

$118.07M

+37.5%

Operating Cash Flow

$145.68M

+32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NXU.DENexus AG
$71.20-0.14%
NVV1.FNovavax, Inc.
$7.50-3.78%
2B4.FBonesupport Holding AB (publ)
$16.82-3.28%
EUZ.DEEckert & Ziegler Strahlen- und Medizintechnik AG
$14.38-4.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$39.66-0.04%
ARTLArtelo Biosciences
$10.27+2.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.66-0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.21+0.04%

Questions About DRW3

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.